Skip to content
Tenfell
Awarded contract
Published 17 Aug 2018

NHS National Framework Agreement for the supply of Human Cell Line Recombinant Factor VIII products

Commercial Medicines Unit · United Kingdom

Key facts

Contract value
£3,750,000
Awarded
01 Jun 2016
Contract starts
30 Jun 2016
Contract ends
31 Mar 2017
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to

SupplierValue
Please refer to "Parties appointed to the framework agreement"£3,750,000

Description

NHS National framework agreement for the supply of Human Cell Line Recombinant Factor VIII products. The framework will commence on 1st July 2016 to 31st March 2017, with options to extend for up to a further 39 months. Please refer to the ITO, Document No.05d for a list of Participating Authorities.

Additional information: The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England, Wales, Scotland and Northern Ireland. The framework may also be used by private sector contractors and agents working on behalf of the above. Please refer to Document 05d in the ITO documents for the list of Participating Authorities

Categories (CPV)

Similar open tenders

About Commercial Medicines Unit

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.